Mylan Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MYLAN LABS, and what generic and branded alternatives to MYLAN LABS drugs are available?
MYLAN LABS has one hundred and forty-eight approved drugs.
There are eleven tentative approvals on MYLAN LABS drugs.
Drugs and US Patents for Mylan Labs
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Labs Ltd | VANCOMYCIN HYDROCHLORIDE | vancomycin hydrochloride | INJECTABLE;INJECTION | 065397-001 | Dec 30, 2008 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mylan Labs Ltd | DOCETAXEL | docetaxel | INJECTABLE;INJECTION | 208859-001 | Apr 30, 2018 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mylan Labs Ltd | OXALIPLATIN | oxaliplatin | INJECTABLE;INTRAVENOUS | 200979-002 | Aug 8, 2012 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Mylan Labs Ltd | CASPOFUNGIN ACETATE | caspofungin acetate | POWDER;INTRAVENOUS | 207650-001 | Sep 29, 2017 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Mylan Labs Ltd | MOXIFLOXACIN HYDROCHLORIDE IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER | moxifloxacin hydrochloride | SOLUTION;INTRAVENOUS | 205833-001 | May 5, 2017 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Mylan Labs Ltd | DOXYCYCLINE | doxycycline hyclate | INJECTABLE;INJECTION | 091406-001 | Aug 21, 2012 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.